![Gregory Chow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Chow
Direttore Finanziario/CFO presso
SUTRO BIOPHARMA, INC.
Patrimonio netto: 156 870 $ in data 30/06/2026
Profilo
Gregory K.
Chow is Chief Financial & Accounting Officer at Sutro Biopharma, Inc. since 2025.
Formerly, Mr. Chow was Chief Financial & Business Officer at NodThera Ltd. from 2024 to 2025, Chief Financial Officer at Aptose Biosciences, Inc. from 2013 to 2021, Managing Director & Director-Private Placements at Wedbush Securities, Inc. from 2012 to 2013, Director-Private Placements at RBC Capital Markets, Inc. from 2006 to 2011, Chief Financial Officer at Freenome Holdings, Inc., Chief Financial Officer at Frontier Medicines Corp., and Senior Auditor at BDO USA PC from 1995 to 1998.
Education includes an undergraduate degree from the University of California, Santa Barbara in 1994 and an MBA from The Wharton School of the University of Pennsylvania in 2005.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/06/2026 | 4.725 ( 0,03% ) | 156 870 $ | 30/06/2026 |
Posizioni attive di Gregory Chow
| Società | Posizione | Inizio |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Direttore Finanziario/CFO | 02/06/2025 |
Precedenti posizioni note di Gregory Chow
| Società | Posizione | Fine |
|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Direttore Finanziario/CFO | 01/03/2025 |
| APTOSE BIOSCIENCES INC. | Direttore Finanziario/CFO | 26/03/2021 |
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Amministratore Delegato | 01/01/2013 |
RBC Capital Markets, Inc.
 RBC Capital Markets, Inc. Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01/01/2011 |
BDO USA PC
 BDO USA PC Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax and financial advisory services | Comptroller/Controller/Auditor | 01/08/1998 |
Formazione di Gregory Chow
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
BDO USA PC
BDO USA PC Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax and financial advisory services | Commercial Services |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Provides investment advice | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Freenome Holdings, Inc.
 Freenome Holdings, Inc. Medical SpecialtiesHealth Technology Operates as an early cancer detection company that develops blood-based screening tests | Health Technology |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Health Technology |
